Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease

Abstract

Patients who received topical budesonide or dexamethasone rinse to treat oral manifestations of cGVHD had decreased cGVHD severity and pain scores after 30 days compared with baseline scores, though no statistical differences were seen between groups.